A case control study of sarcosine as an early prostate cancer detection biomarker

被引:28
作者
Ankerst, Donna P. [1 ,2 ,3 ]
Liss, Michael [2 ]
Zapata, David [2 ]
Hoefler, Josef [1 ]
Thompson, Ian M. [2 ]
Leach, Robin J. [2 ,4 ]
机构
[1] Tech Univ Munich, Dept Math, D-85748 Garching, Germany
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA
[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
Sarcosine; Prostate cancer; Prostate-specific antigen; SERUM SARCOSINE;
D O I
10.1186/s12894-015-0095-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Sarcosine has been investigated as a prostate cancer biomarker with mixed results concerning its predictive power. We performed a case-control evaluation of the predictive value of serum sarcosine for early detection in a population-based cohort of men undergoing prostate-specific antigen (PSA) screening. Methods: For analysis we used 251 cancer cases and 246 age-matched non-cancer cases from the San Antonio Biomarkers Of Risk (SABOR) screening study. For cancer cases, pre-diagnostic serum was utilized for sarcosine measurement. Controls were defined as men who had been followed at least for 5 years on study with no prostate cancer diagnosis; sarcosine was measured on the initial baseline serum. HPLC-electrospray ionization mass spectrometry was used for serum sarcosine quantification. The association of sarcosine with prostate cancer was assessed using area underneath the receiver-operating characteristic curve (AUC), and logistic regression adjusting for PSA, digital rectal exam, family history, age, race, and history of a prior negative biopsy. Among cancer cases, nominal logistic regression was used for the association of sarcosine with Gleason grade. Results: Sarcosine levels were overlapping between the prostate cancer cases (median 15.8 uM, range 6.2 to 42.5 uM) and controls (median 16.2 uM, range 6.4 to 53.6 uM). The AUC of sarcosine was not statistically different from random chance either for participants with any PSA value (52.2 %) or those with PSA values in the range of 2 to 10 ng/mL (54.3 %). Sarcosine was not predictive of Gleason score and added no independent predictive power to standard prostate cancer risk factors for detection of prostate cancer (all p-values > 0.05). Conclusions: Serum sarcosine should not be pursued further as a marker for the early detection of prostate cancer.
引用
收藏
页数:4
相关论文
共 9 条
[1]   Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine [J].
Cao, D-L ;
Ye, D-W ;
Zhu, Y. ;
Zhang, H-L ;
Wang, Y-X ;
Yao, X-D .
PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (02) :166-172
[2]   Sarcosine as a Potential Prostate Cancer Biomarker-A Review [J].
Cernei, Natalia ;
Heger, Zbynek ;
Gumulec, Jaromir ;
Zitka, Ondrej ;
Masarik, Michal ;
Babula, Petr ;
Eckschlager, Tomas ;
Stiborova, Marie ;
Kizek, Rene ;
Adam, Vojtech .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (07) :13893-13908
[3]   Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer-A large nested case-control study within the JANUS cohort in Norway [J].
de Vogel, Stefan ;
Ulvik, Arve ;
Meyer, Klaus ;
Ueland, Per Magne ;
Nygard, Ottar ;
Vollset, Stein Emil ;
Tell, Grethe S. ;
Gregory, Jesse F., III ;
Tretli, Steinar ;
Bjorge, Tone .
INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (01) :197-206
[4]   Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours [J].
Jentzmik, Florian ;
Stephan, Carsten ;
Miller, Kurt ;
Schrader, Mark ;
Erbersdobler, Andreas ;
Kristiansen, Glen ;
Lein, Michael ;
Jung, Klaus .
EUROPEAN UROLOGY, 2010, 58 (01) :12-18
[5]   Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial [J].
Koutros, Stella ;
Meyer, Tamra E. ;
Fox, Stephen D. ;
Issaq, Haleem J. ;
Veenstra, Timothy D. ;
Huang, Wen-Yi ;
Yu, Kai ;
Albanes, Demetrius ;
Chu, Lisa W. ;
Andriole, Gerald ;
Hoover, Robert N. ;
Hsing, Ann W. ;
Berndt, Sonja I. .
CARCINOGENESIS, 2013, 34 (10) :2281-2285
[6]   Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers [J].
Liang, Yuanyuan ;
Ankerst, Donna P. ;
Ketchum, Norma S. ;
Ercole, Barbara ;
Shah, Girish ;
Shaughnessy, John D. ;
Leach, Robin J. ;
Thompson, Ian M. .
JOURNAL OF UROLOGY, 2011, 185 (01) :104-110
[7]   Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0?ng/ml [J].
Lucarelli, Giuseppe ;
Fanelli, Margherita ;
Larocca, Angela Maria Vittoria ;
Germinario, Cinzia Annatea ;
Rutigliano, Monica ;
Vavallo, Antonio ;
Selvaggi, Francesco Paolo ;
Bettocchi, Carlo ;
Battaglia, Michele ;
Ditonno, Pasquale .
PROSTATE, 2012, 72 (15) :1611-1621
[8]   Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression [J].
Sreekumar, Arun ;
Poisson, Laila M. ;
Rajendiran, Thekkelnaycke M. ;
Khan, Amjad P. ;
Cao, Qi ;
Yu, Jindan ;
Laxman, Bharathi ;
Mehra, Rohit ;
Lonigro, Robert J. ;
Li, Yong ;
Nyati, Mukesh K. ;
Ahsan, Aarif ;
Kalyana-Sundaram, Shanker ;
Han, Bo ;
Cao, Xuhong ;
Byun, Jaeman ;
Omenn, Gilbert S. ;
Ghosh, Debashis ;
Pennathur, Subramaniam ;
Alexander, Danny C. ;
Berger, Alvin ;
Shuster, Jeffrey R. ;
Wei, John T. ;
Varambally, Sooryanarayana ;
Beecher, Christopher ;
Chinnaiyan, Arul M. .
NATURE, 2009, 457 (7231) :910-914
[9]   GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization [J].
Wu, Hao ;
Liu, Taotao ;
Ma, Chunguang ;
Xue, Ruyi ;
Deng, Chunhui ;
Zeng, Huazong ;
Shen, Xizhong .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 401 (02) :635-646